Skip to content

Goal-Directed Therapy in Cancer Surgery

Goal-directed Resuscitation in High-risk Patients Undergoing Major Cancer Surgery: a Controlled and Randomized Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01946269
Acronym
GRICS II
Enrollment
128
Registered
2013-09-19
Start date
2013-09-30
Completion date
2014-05-31
Last updated
2013-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Care

Brief summary

The purpose of this study is to determine whether a goal-directed resuscitation therapy within the first 8 hours after major abdominal cancer surgery reduces postoperative complications compared to a standard therapy.

Interventions

* A target value of a cardiac index (CI) greater than 2.5 L/min/m2 and a mean arterial pressure of 70 mmHg will be sought. * The first step will be fluid resuscitation with 200ml aliquots of Lactated Ringer's solution plus human albumin 20% 50 mL whenever the CI is lower than 2.5 L/min/m2. The fluid challenge will be stopped if the CVP rises by more than 4 mmHg during the infusion period or CI increases less than 10%. * When the CI is lower than or equal to 2.5L/min/m2 despite of fluid challenge, dobutamine will be initiated with increasing doses up to 20mcg/kg/min. * The final step will be red blood transfusion to reach a hematocrit higher than 28%. * If necessary, norepinephrine infusion will be used to maintain a mean arterial pressure above 70 mmHg.

The control group will be managed by the surgical ICU staff in the postoperative period according to institutional protocol of hemodynamic monitoring.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients admitted to ICU in immediate postoperatory of major abdominal surgery for cancer treatment * Age over 18 years-old

Exclusion criteria

* Weight under 55 kilograms or over 140 kilograms; * Contra-indication for invasive hemodynamic monitoring; * Expected ICU permanence less than 24 hours; * Active bleeding * Vasoplegic shock with noradrenaline dose higher than 1mcg/kg/min * Enrolled in other study * Refuse to consent

Design outcomes

Primary

MeasureTime frameDescription
Composite endpoint of death or major postoperative complications30 days after randomizationDeath or one of the following complications: stroke, renal failure, respiratory complications, cardiovascular complications, deep wound infection and reoperation for any reason.

Secondary

MeasureTime frameDescription
Severe Renal complication30 days after randomizationSevere renal complication will be defined as renal failure according to Acute Kidney Injury Network (AKIN) stage 3.
Cardiovascular complications30 days after randomizationTo compare the incidence of cardiovascular complications between groups. Cardiovascular complications will be defined as myocardial ischemia, acute decompensated heart failure, mesenteric ischemia, pulmonary thromboembolism and peripheral vascular ischemia.
Duration of ICU stay and hospital stay30 days after randomizationTo compare the number of days of ICU stay and hospital stay between groups.
Tissue hypoperfusion markers7 days after randomizationTo compare levels of DO2, lactate, ScvO2, base excess and venous to arterial carbon dioxide difference between groups.
Respiratory complications30 days after randomizationRespiratory complication will be defined as acute distress respiratory syndrome according to Berlin criteria
Neurological complications30 days after randomizationTo compare the incidence of stroke between groups within 30 days after randomization.
Severe infectious complications30 days after randomizationTo compare the incidence, between groups, of infectious complications defined as a new septic shock.
Surgical complications30 days after randomizationTo compare the incidence between groups of surgical complication. Surgical complication will be defined as reoperation due to any reason, hospital readmission or death
Daily SOFA score7 days after randomizationDaily sequential organ failure assessment score within the first 7 days after randomization

Countries

Brazil

Contacts

Primary ContactAline Müller, MD
dra.alinemuller@gmail.com55-11-974130225

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026